Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

317 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Novel half-life extended anti-MIF nanobodies protect against endotoxic shock.
Sparkes A, De Baetselier P, Brys L, Cabrito I, Sterckx YG, Schoonooghe S, Muyldermans S, Raes G, Bucala R, Vanlandschoot P, Van Ginderachter JA, Stijlemans B. Sparkes A, et al. Among authors: de baetselier p. FASEB J. 2018 Jun;32(6):3411-3422. doi: 10.1096/fj.201701189R. Epub 2018 Jan 25. FASEB J. 2018. PMID: 29401625 Free PMC article.
Hence, Nbs, with their structural and pharmacologic advantages over currently available inhibitors, may be an effective, novel approach to interfere with the action of MIF in septic shock and other conditions of inflammatory end-organ damage.-Sparkes, A., De Baetselier
Hence, Nbs, with their structural and pharmacologic advantages over currently available inhibitors, may be an effective, novel approach to i …
MIF contributes to Trypanosoma brucei associated immunopathogenicity development.
Stijlemans B, Leng L, Brys L, Sparkes A, Vansintjan L, Caljon G, Raes G, Van Den Abbeele J, Van Ginderachter JA, Beschin A, Bucala R, De Baetselier P. Stijlemans B, et al. Among authors: de baetselier p. PLoS Pathog. 2014 Sep 25;10(9):e1004414. doi: 10.1371/journal.ppat.1004414. eCollection 2014 Sep. PLoS Pathog. 2014. PMID: 25255103 Free PMC article.
The non-mammalian MIF superfamily.
Sparkes A, De Baetselier P, Roelants K, De Trez C, Magez S, Van Ginderachter JA, Raes G, Bucala R, Stijlemans B. Sparkes A, et al. Among authors: de baetselier p, de trez c. Immunobiology. 2017 Mar;222(3):473-482. doi: 10.1016/j.imbio.2016.10.006. Epub 2016 Oct 12. Immunobiology. 2017. PMID: 27780588 Free PMC article. Review.
Reprint of: The non-mammalian MIF superfamily.
Sparkes A, De Baetselier P, Roelants K, De Trez C, Magez S, Van Ginderachter JA, Raes G, Bucala R, Stijlemans B. Sparkes A, et al. Among authors: de baetselier p, de trez c. Immunobiology. 2017 Jun;222(6):858-867. doi: 10.1016/j.imbio.2017.05.004. Epub 2017 May 26. Immunobiology. 2017. PMID: 28552269 Review.
Nanobodies as novel agents for cancer therapy.
Revets H, De Baetselier P, Muyldermans S. Revets H, et al. Among authors: de baetselier p. Expert Opin Biol Ther. 2005 Jan;5(1):111-24. doi: 10.1517/14712598.5.1.111. Expert Opin Biol Ther. 2005. PMID: 15709914 Review.
Nanobodies as tools for in vivo imaging of specific immune cell types.
De Groeve K, Deschacht N, De Koninck C, Caveliers V, Lahoutte T, Devoogdt N, Muyldermans S, De Baetselier P, Raes G. De Groeve K, et al. Among authors: de baetselier p, de koninck c. J Nucl Med. 2010 May;51(5):782-9. doi: 10.2967/jnumed.109.070078. Epub 2010 Apr 15. J Nucl Med. 2010. PMID: 20395332 Free article.
317 results